Targeted nano-enhanced optical delivery of opsin for dry-AMD therapy

Ended Project Grant Awarded Last action

Award ID
R44EY031642
Recipient
Awarding agency
Obligated
$4,128,187

Award facts

Assistance listing
93.867 Vision Research
Completion date
Originally
Funding
  • $3,449,561.00 Federal
  • $678,626.00 Non-federal
Place of performance
Texas, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $656,220 $0
Amendment $656,220 $0
Amendment $678,626 $0
Amendment Targeted nano-enhanced optical delivery of opsin for dry-AMD therapy - geographic atrophies (GA) in dry-age related macular degeneration (AMD) is… $678,626 $678,626
Original award $779,869 $0

Quick answers

Who received award R44EY031642?

R44EY031642 was awarded to Nanoscope Technologies LLC by National Eye Institute (National Institutes of Health) on June 1, 2020.

How much is award R44EY031642 worth?

$4,128,187 has been obligated on R44EY031642: $3,449,561 in federal funding and $678,626 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award